Literature DB >> 9284703

Augmentation of bone mineral density in hirsute women.

S Dagogo-Jack1, N al-Ali, M Qurttom.   

Abstract

Hirsutism is associated with both hyperandrogenism and oligomenorrhea or amenorrhea, which have opposing effects on bone mineral density (BMD). We tested the hypothesis that hyperandrogenism in hirsute women counteracts the osteopenic effects of menstrual dysfunction. Using dual energy x-ray absorptiometry, we measured BMD and total bone mineral content (BMC) in 32 young women referred for hirsutism. The control group consisted of 25 matched, nonhirsute women. Among the hirsute women, 21 reported regular menses, and 11 gave a history of oligomenorrhea; all members of the control group reported regular menses. Compared with controls, hirsute women had higher total BMD (1.202 +/- 0.02 vs. 1.116 +/- 0.02 g/cm2, P < 0.01), lumbar spine BMD (1.183 +/- 0.02 vs. 1.125 +/- 0.02 g/cm2, P < 0.01), and total BMC (2700 +/- 66 vs. 2400 +/- 70 g, P < 0.001). Serum total testosterone levels were similar, but androstenedione levels were higher (11.7 +/- 0.80 vs. 7.9 +/- 0.79 nmol/L, P < 0.005) and sex hormone binding globulin levels lower (22.0 +/- 3.0 vs. 57.6 +/- 8.5 nmol/L, P < 0.001) in hirsute women than controls. Oligomenorrheic hirsute women had higher BMD than nonhirsute women, although the augmentation was less pronounced than in eumenorrheic hirsute women. These results indicate that hirsutism is associated with higher bone density and mineral content, consistent with a net positive effect of hyperandrogenism on skeletal mass.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284703     DOI: 10.1210/jcem.82.9.4246

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls.

Authors:  A B Sopher; J C Thornton; M E Silfen; A Manibo; S E Oberfield; J Wang; R N Pierson; L S Levine; M Horlick
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 2.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

3.  Association Between Insulin Resistance and Bone Structure in Nondiabetic Postmenopausal Women.

Authors:  Vikram V Shanbhogue; Joel S Finkelstein; Mary L Bouxsein; Elaine W Yu
Journal:  J Clin Endocrinol Metab       Date:  2016-05-31       Impact factor: 5.958

4.  Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.

Authors:  Camila F Pereira-Eshraghi; Codruta Chiuzan; Yuan Zhang; Rachel H Tao; Matthew McCann; Y Dana Neugut; Alison Printz; Ilene Fennoy; Melanie Cree-Green; Sharon E Oberfield; Aviva B Sopher
Journal:  Horm Res Paediatr       Date:  2020-04-29       Impact factor: 2.852

Review 5.  Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.

Authors:  M P Hage; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-09-06       Impact factor: 4.507

Review 6.  DHEA and the skeleton (through the ages).

Authors:  C M Gordon; J Glowacki; M S LeBoff
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

7.  GH-binding protein is related to bone mineral density in non-obese androgenized women.

Authors:  M Legan; J Osredkar; S Fisker; A Kocijancic
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

8.  Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Authors:  Zehra Berberoglu; Aynur Aktas; Yasemin Fidan; Ayse Canan Yazici; Yalcin Aral
Journal:  J Bone Miner Metab       Date:  2014-01-16       Impact factor: 2.626

9.  Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

Authors:  D Glintborg; A P Hermann; L M Rasmussen; M Andersen
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

Review 10.  Sex hormones, their receptors and bone health.

Authors:  K Venken; F Callewaert; S Boonen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.